Aldinucci D, Borghese C, Casagrande N (2019) Formation of the immunosuppressive microenvironment of classic Hodgkin lymphoma and therapeutic approaches to counter it. Int J Mol Sci 20:2416. https://doi.org/10.3390/ijms20102416

Article  CAS  PubMed  PubMed Central  Google Scholar 

Weniger MA, Küppers R (2021) Molecular biology of Hodgkin lymphoma. Leukemia 35:968–981. https://doi.org/10.1038/s41375-021-01204-6

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wang HW, Balakrishna JP, Pittaluga S, Jaffe ES (2019) Diagnosis of Hodgkin lymphoma in the modern era. Br J Haematol 184:45–59. https://doi.org/10.1111/bjh.15614

Article  PubMed  Google Scholar 

Cader FZ, Schackmann RC, Hu X, Wienand K, Redd R, Chapuy B et al (2018) Mass cytometry of Hodgkin lymphoma reveals a CD4+ regulatory T-cell–rich and exhausted T-effector microenvironment. Blood 132:825–836. https://doi.org/10.1182/blood-2018-04-843714

Article  CAS  PubMed  PubMed Central  Google Scholar 

Greaves P, Clear A, Owen A, Iqbal S, Lee A, Matthews J et al (2013) Defining characteristics of classical Hodgkin lymphoma microenvironment T-helper cells. Blood 122:2856–2863. https://doi.org/10.1182/blood-2013-06-508044

Article  CAS  PubMed  PubMed Central  Google Scholar 

Patel SS, Weirather JL, Lipschitz M, Lako A, Chen P-H, Griffin GK et al (2019) The microenvironmental niche in classic Hodgkin lymphoma is enriched for CTLA-4–positive T cells that are PD-1–negative. Blood 134:2059–2069. https://doi.org/10.1182/blood.2019002206

Article  PubMed  PubMed Central  Google Scholar 

Gholiha AR, Hollander P, Hedstrom G, Sundstrom C, Molin D, Smedby KE et al (2019) High tumour plasma cell infiltration reflects an important microenvironmental component in classic Hodgkin lymphoma linked to presence of B-symptoms. Br J Haematol 184:192–201. https://doi.org/10.1111/bjh.15703

Article  CAS  PubMed  Google Scholar 

Ahn SS, Song JJ, Park YB, Lee SW (2017) Malignancies in Korean patients with immunoglobulin G4-related disease. Int J Rheum Dis 20:1028–1035. https://doi.org/10.1111/1756-185X.13093

Article  CAS  PubMed  Google Scholar 

Kiil K, Bein J, Schuhmacher B, Thurner L, Schneider M, Hansmann M-L et al (2018) A high number of IgG4-positive plasma cells rules out nodular lymphocyte predominant Hodgkin lymphoma. Virchows Arch 473:759–764. https://doi.org/10.1007/s00428-018-2460-8

Article  CAS  PubMed  Google Scholar 

Karagiannis P, Gilbert AE, Josephs DH, Ali N, Dodev T, Saul L et al (2013) IgG4 subclass antibodies impair antitumor immunity in melanoma. J Clin Invest 123:1457–1474. https://doi.org/10.1172/JCI65579

Article  CAS  PubMed  PubMed Central  Google Scholar 

Yamamoto M, Takahashi H, Tabeya T, Suzuki C, Naishiro Y, Ishigami K et al (2012) Risk of malignancies in IgG4-related disease. Mod Rheumatol 22:414–418. https://doi.org/10.1007/s10165-011-0520-x

Article  CAS  PubMed  Google Scholar 

Sohn EJ, Ahn HB, Roh MS, Jung WJ, Ryu WY, Kwon YH (2018) Immunoglobulin G4 (IgG4)-positive ocular adnexal mucosa-associated lymphoid tissue lymphoma and idiopathic orbital inflammation. Ophthalmic Plast Reconstr Surg 34:313–319. https://doi.org/10.1097/IOP.0000000000000965

Article  PubMed  Google Scholar 

Bledsoe JR, Wallace ZS, Stone JH, Deshpande V, Ferry JA (2018) Lymphomas in IgG4-related disease: clinicopathologic features in a Western population. Virchows Arch 472:839–852. https://doi.org/10.1007/s00428-017-2286-9

Article  CAS  PubMed  Google Scholar 

Ferry JA (2013) IgG4-related lymphadenopathy and IgG4-related lymphoma: moving targets. Diagn Histopathol 19:128–139. https://doi.org/10.1016/j.mpdhp.2013.01.005

Article  Google Scholar 

Takahashi N, Ghazale AH, Smyrk TC, Mandrekar JN, Chari ST (2009) Possible association between IgG4-associated systemic disease with or without autoimmune pancreatitis and non-Hodgkin lymphoma. Pancreas 38:523–526. https://doi.org/10.1097/MPA.0b013e31819d73ca

Article  PubMed  Google Scholar 

Nowak V, Agaimy A, Kristiansen G, Gütgemann I (2020) Increased IgG4-positive plasma cells in nodular-sclerosing Hodgkin lymphoma: a diagnostic pitfall. Histopathology 76:244–250. https://doi.org/10.1111/his.13965

Article  PubMed  Google Scholar 

Deshpande V, Zen Y, Chan JK, Yi EE, Sato Y, Yoshino T et al (2012) Consensus statement on the pathology of IgG4-related disease. Mod Pathol 25:1181–92. https://doi.org/10.1038/modpathol.2012.72

Article  PubMed  Google Scholar 

Glimelius I, Diepstra A (2017) Novel treatment concepts in Hodgkin lymphoma. J Intern Med 281:247–260. https://doi.org/10.1111/joim.12582

Article  CAS  PubMed  Google Scholar 

Brice P, de Kerviler E, Friedberg JW (2021) Classical Hodgkin lymphoma. Lancet 398:1518–1527. https://doi.org/10.1016/S0140-6736(20)32207-8

Article  PubMed  Google Scholar 

Nishikori A, Nishimura Y, Shibata R, Ohshima K-i, Gion Y, Ikeda T et al (2021) Upregulated expression of activation-induced cytidine deaminase in ocular adnexal marginal zone lymphoma with IgG4-positive cells. Int J Mol Sci. 22:4083. https://doi.org/10.3390/ijms22084083

Article  CAS  PubMed  PubMed Central  Google Scholar 

Cheuk W, Tam FK, Chan AN, Luk IS, Yuen AP, Chan W-K et al (2010) Idiopathic cervical fibrosis—a new member of IgG4-related sclerosing diseases: report of 4 cases, 1 complicated by composite lymphoma. Am J Surg Pathol 34:1678–1685. https://doi.org/10.1097/PAS.0b013e3181f12c85

Article  PubMed  Google Scholar 

Vardhana S, Younes A (2016) The immune microenvironment in Hodgkin lymphoma: T cells, B cells, and immune checkpoints. Haematologica 101:794. https://doi.org/10.3324/haematol.2015.132761

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bianchini R, Karagiannis SN, Jordakieva G, Jensen-Jarolim E (2020) The role of IgG4 in the fine tuning of tolerance in IgE-mediated allergy and cancer. Int J Mol Sci 21:5017. https://doi.org/10.3390/ijms21145017

Article  CAS  PubMed  PubMed Central  Google Scholar 

Sato Y, Notohara K, Kojima M, Takata K, Masaki Y, Yoshino T (2010) IgG4-related disease: historical overview and pathology of hematological disorders. Pathol Int 60:247–258. https://doi.org/10.1111/j.1440-1827.2010.02524.x

Article  CAS  PubMed  Google Scholar 

Cheuk W, Yuen HK, Chan AC, Shih L-Y, Kuo T-T, Ma M-W et al (2008) Ocular adnexal lymphoma associated with IgG4+ chronic sclerosing dacryoadenitis: a previously undescribed complication of IgG4-related sclerosing disease. Am J Surg Pathol 32:1159–1167. https://doi.org/10.1097/PAS.0b013e31816148ad

Article  PubMed  Google Scholar 

Mitsui T, Yokohama A, Koiso H, Ishizaki T, Uchiumi H, Saitoh T et al (2013) Development of IgG4-related disease 10 years after chemotherapy for diffuse large B cell lymphoma and longstanding bronchial asthma. Int J Hematol 98:122–128. https://doi.org/10.1007/s12185-013-1359-z

Article  PubMed  Google Scholar 

Matsuo T, Ichimura K, Yoshino T (2011) Local recurrence as immunoglobulin G4 (IgG4)-related disease 10 years after radiotherapy to ocular adnexal extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue. J Clin Exp Hematop 51:125–133. https://doi.org/10.3960/jslrt.51.125

Article  PubMed  Google Scholar